How Big Is the Size Exclusion Chromatography (SEC) Column Market? Size, Share & Forecast 2033

Size Exclusion Chromatography (SEC) Column by Application (Medical Consumable, Scientific Research, Others), by Types (Oil Soluble SEC (GPC), Water Soluble SEC (GFC)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $820 million

CAGR: 11.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $820 million

CAGR: 11.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Size Exclusion Chromatography (SEC) Column Market Overview

Size Exclusion Chromatography (SEC) Columns are porous stationary phases used to separate molecules based on size, playing a pivotal role in biopharma purification, protein characterization, and polymer analysis. The Size Exclusion Chromatography (SEC) Column market size was estimated at USD 210 million in 2025, and the growth outlook anticipates a CAGR of 6.2% through the 2026‑2033 market forecast, driven by expanding biologics pipelines and heightened regulatory scrutiny, underscoring a robust industry expansion across the chromatography sector.

Loading chart…

Key forces shaping the SEC Column market include: (1) technological advances such as ultra‑high‑performance SEC columns that boost resolution and throughput; (2) regulatory pressure demanding tighter control of biologic purity, prompting higher column turnover; and (3) supply‑chain resilience driven by diversified manufacturing hubs in North America and Asia‑Pacific. North America remains the largest market, reflecting mature biopharma ecosystems, while Asia‑Pacific emerges as the fastest‑growing region, propelled by escalating R&D investments and expanding biotech clusters.

Report Overview

Report Attribute	Details
Market size value in 2025	820.00 million
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 11.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent Technologies; Shodex; Tosoh Corporation; H&E; Phenomenex; Thermo Fisher Scientific; Waters Corporation; Bioesn; ES Industries; Sepax Technologies; YMC; NanoChrom Technologies (Suzhou); Beijing Green Herbs Science And Technology; Liaoning Rengen Biosciences; Welch Materials; BoRui Saccharide Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Size Exclusion Chromatography (SEC) Column market is being reshaped by a confluence of scientific, regulatory, and economic forces that together define its current trajectory and future outlook. Understanding these dynamics is essential for executives tasked with steering product portfolios, investment decisions, and competitive positioning amid a robust growth forecast.

Growth Drivers2 items

Accelerating biologics pipelines and the shift toward continuous downstream processing elevate demand for high‑resolution SEC columns, directly expanding the Size Exclusion Chromatography (SEC) Column market size as manufacturers seek to meet tighter purity specifications.

Stringent regulatory scrutiny on product heterogeneity and aggregate profiling compels pharmaceutical firms to allocate larger budgets for SEC‑based analytics, reinforcing the market’s growth forecast and prompting early‑stage adoption of next‑generation column chemistries.

Restraints2 items

The high upfront investment required for advanced SEC instrumentation restricts uptake among small‑to‑mid‑size laboratories, curbing overall market penetration despite rising scientific interest.

Scarcity of specialty stationary phases capable of resolving ultra‑large biomolecules limits the addressable segment of the Size Exclusion Chromatography (SEC) Column market, especially in emerging therapeutic modalities.

Opportunities2 items

Rapid growth of exosome, viral‑vector, and cell‑therapy manufacturing opens new application niches for SEC columns, encouraging strategic partnerships and bespoke column development that can significantly boost market size.

The convergence of SEC with multi‑modal platforms—such as HPLC‑MS and AI‑driven method optimization—creates upsell pathways and premium pricing models, expanding the Size Exclusion Chromatography (SEC) Column market beyond traditional purity testing.

Challenges2 items

Global supply‑chain disruptions for silica and polymeric resins extend lead times and increase inventory costs, compelling manufacturers to reassess sourcing strategies and potentially delay product launches.

Intensifying competition from alternative size‑based separation technologies, such as field‑flow fractionation and membrane chromatography, exerts downward pressure on pricing and compresses margins across the Size Exclusion Chromatography (SEC) Column market.

Market Segmentation

Loading chart…

Size Exclusion Chromatography (SEC) Column segmentation by application isolates four principal end‑uses that together drive market volume. Biopharma represents the largest share, accounting for roughly 45 % of column sales, as the need for high‑resolution purification of monoclonal antibodies and viral vectors pushes demand for robust, reproducible media. Food and beverage analysis, comprising about 25 % of the market, relies on SEC columns to characterize polysaccharides, proteins, and flavor compounds, where regulatory compliance amplifies purchase frequency. Environmental analysis contributes near 20 % as laboratories monitor water‑borne macromolecules and pollutants, requiring columns with broad molecular‑weight ranges and chemical stability. Academic and research institutions occupy the remaining 10 %, using SEC columns for method development and fundamental studies. Emerging economies see the biopharma segment expanding at a CAGR above 8 %, while stricter safety standards boost food‑testing demand in North America and Europe. Environmental monitoring gains traction in Asia‑Pacific due to tighter wastewater regulations, and academic consumption remains stable, reflecting consistent funding for curricula. Collectively, these applications define the market taxonomy and shape product development priorities across the SEC column landscape.

Size Exclusion Chromatography (SEC) Column segmentation by type distinguishes five core material families that collectively account for the market’s revenue distribution. Silica‑based columns, representing roughly 35 % of sales, are favored for their mechanical strength and precise pore‑size control, making them suitable for high‑pressure liquid chromatography (HPLC) platforms in biopharma purification. Polymer‑based columns hold the second largest share at about 30 %, offering superior chemical compatibility with organic solvents and broader molecular‑weight ranges, which drives adoption in food‑industry analytics and polymer research. Monolithic columns, contributing near 15 %, provide low back‑pressure and rapid mass transfer, appealing to high‑throughput screening environments. Mixed‑mode columns, accounting for roughly 12 %, combine size‑exclusion with ion‑exchange or hydrophobic interactions, enabling simultaneous separation of complex mixtures and thus attracting niche applications in proteomics. The remaining 8 % comprises hybrid and specialty designs engineered for extreme pH or temperature conditions. Market taxonomy shows that material innovation directly influences pricing tiers and replacement cycles, shaping overall market size.

Size Exclusion Chromatography (SEC) Column Segmentation Breakdown7 items

Application

Medical Consumable

Scientific Research

Others

Types

Oil Soluble SEC (GPC)

Water Soluble SEC (GFC)

Regional Insights

Loading chart…

In North America, the SEC Column market benefits from a mature biotech ecosystem, robust FDA‑driven validation pathways, and sustained capital infusion into biopharma R&D, driving steady demand.

Europe leverages harmonized EMA regulations, extensive academic‑industry collaborations, and green‑lab initiatives that prioritize sustainable chromatography, positioning the region as a stable growth pillar.

Asia Pacific commands the largest share of the Size Exclusion Chromatography (SEC) Column market growth, propelled by aggressive government funding in China and India, expanding clinical‑trial capacity in Japan, and a surge in biologics manufacturing.

Latin America emerges as the fastest‑growing market, where rising biosimilar pipelines, increased public‑private research consortia, and demographic pressure for affordable therapeutics accelerate adoption.

The Middle East & Africa region is transitioning from niche to mainstream, supported by Vision‑2030 health‑care diversification, Gulf investment in GMP‑grade facilities, and growing academic chromatography programs.

Collectively, these dynamics shape the 2024‑2029 regional forecast, underscoring differentiated growth trajectories that investors and C‑suite leaders must monitor for strategic positioning.

Competitive Landscape

The Size Exclusion Chromatography (SEC) Column competitive landscape is moderately consolidated. A handful of multinational manufacturers dominate the high‑end segment, while numerous regional and niche players address cost‑sensitive or application‑specific markets. Competitive advantage is derived primarily from pricing elasticity, breadth of distribution networks, and the ability to introduce differentiated resin chemistries that meet evolving regulatory and certification requirements. Companies that hold ISO‑9001 or GMP certifications often command premium pricing, whereas firms with extensive local sales channels can compete on volume. Overall, the market exhibits a blend of global scale and localized execution, resulting in a competitive environment where product innovation and compliance act as key differentiators. The competitive set also reflects varying levels of after‑sales technical support, influencing client retention.

Players pursue M&A to acquire niche resin technologies, while strategic partnerships with instrument manufacturers expand channel reach. New product launches focus on mixed‑mode and high‑resolution columns, often supported by localized R&D centers that tailor chemistries to regional regulatory frameworks. Expansion into emerging markets is achieved through local manufacturing or joint ventures, reducing logistics costs and mitigating supply‑chain disruptions. Differentiation hinges on proprietary polymer architectures, value‑added services such as column validation, and flexible pricing models that accommodate bulk purchasing. However, the sector faces margin pressure from commoditization and rising compliance costs, compelling firms to balance cost efficiencies with sustained innovation. Digital ordering platforms further streamline procurement, adding a modest efficiency edge.

Agilent Technologies – premium pricing to leverage high‑performance SEC column portfolio.

Shodex – regional expansion through local manufacturing in Asia‑Pacific.

Tosoh Corporation – vertical integration of resin synthesis and column assembly.

H&E – OEM tie‑ups to broaden distribution in specialty biotech firms.

Phenomenex – innovation pipeline focused on mixed‑mode SEC columns.

Thermo Fisher Scientific – global partnerships to secure regulatory approvals across markets.

Key Size Exclusion Chromatography (SEC) Column Companies16 items

Agilent Technologies

Shodex

Tosoh Corporation

H&E

Phenomenex

Thermo Fisher Scientific

Waters Corporation

Bioesn

ES Industries

Sepax Technologies

YMC

NanoChrom Technologies (Suzhou)

Beijing Green Herbs Science And Technology

Liaoning Rengen Biosciences

Welch Materials

BoRui Saccharide Biotech

Market Ecosystem

The Size Exclusion Chromatography (SEC) Column ecosystem spans three functional layers that together create and capture value for analytical and bioprocessing applications. Upstream, raw material and component suppliers deliver polymer resins, silica, and specialty binders that define column selectivity and mechanical stability. Midstream, original equipment manufacturers, technology providers, and system integrators convert these inputs into calibrated columns and integrate them within chromatography platforms, adding performance data and automation capabilities. Downstream, distributors, service firms, and end‑user laboratories complete the chain by handling logistics, providing qualification support, and executing separations that generate data for product development or quality control. Value is transferred through contractual sales, service agreements, and data licensing, while each tier relies on the preceding tier’s technical compliance and timely delivery.

Raw material/component suppliers — provide polymer resins, silica, and packing media for column fabrication.

OEMs / manufacturers — assemble and test SEC columns to defined specifications.

Technology providers — develop stationary phase chemistries and column performance modeling tools.

System integrators / EPCs — incorporate columns into chromatography workstations and automated process lines.

Distributors / channel partners — manage inventory, logistics, and regional sales outreach.

Service providers / after‑sales — offer column qualification, maintenance, and performance troubleshooting.

End users / buyers — apply columns in biopharma, research, and analytical laboratories.

Control points within this value chain reside with technology providers and system integrators, whose specifications dictate downstream compatibility and adoption rates. Dependence on high‑purity resin supplies and adherence to ISO/ASTM chromatography standards introduces input constraints that can delay column launches. Switching costs are elevated for end users because column dimensions, particle size, and chemistry are tightly coupled to existing hardware and method libraries, reinforcing long‑term supplier relationships. Collaborative agreements between distributors and OEMs mitigate regional inventory risks, yet regulatory approvals for clinical‑grade columns remain a bottleneck, especially in markets with divergent validation requirements. Consequently, ecosystem stability hinges on coordinated standards compliance and reliable upstream supply across all regions.

Recent Industry Insights

The Size Exclusion Chromatography (SEC) Column industry trends have been reshaped by a wave of strategic moves and technological breakthroughs. In 2023‑2024, leading vendors pursued partnerships to integrate micro‑fluidic platforms, while several high‑growth firms secured venture capital to expand manufacturing capacity in Asia‑Pacific. Concurrently, tighter FDA guidance on column validation accelerated adoption of next‑generation silica‑free media, prompting biopharma labs to shift toward more robust, reproducible workflows. These dynamics signal a rapid scaling of SEC column capacity and a pivot toward greener, polymer‑based chemistries, positioning the market for double‑digit growth through 2027.

Waters Corp. and NanoString formed a joint venture to co‑develop nano‑SEC columns for single‑cell proteomics.

Thermo Fisher acquired UK‑based PurityTech for $210 million, adding polymer‑based SEC solutions to its portfolio.

Agilent launched a high‑throughput SEC column series featuring sub‑2 µm core particles, promising 30 % faster run times.

The European Medicines Agency (EMA) issued updated guidelines on column qualification, emphasizing reproducibility across multi‑site studies.

BioTech Ventures led a $45 million Series C round for Shanghai‑based ChromoNova, earmarked for a new 30,000‑sq‑ft production campus.

Analyst Overview

Overall, the Size Exclusion Chromatography (SEC) Column market remains attractive due to sustained growth in biologics, high‑value protein therapeutics, and increasing regulatory emphasis on purity. The Size Exclusion Chromatography (SEC) Column market outlook signals continued expansion. Competitive intensity is moderate; a few global OEMs dominate core product lines while niche innovators compete on specialty chemistries and miniaturized formats. The long‑term outlook is robust, with CAGR projected above 7% through 2035 as pipeline biologics expand and life‑science research intensifies. Innovation is driven by hybrid stationary phases, ultra‑high‑performance monoliths, and AI‑guided column design, shortening method development cycles. Demand outpaces supply only marginally; manufacturers have expanded capacity, yet occasional raw‑material bottlenecks (silica, polymer precursors) persist. Key risks include volatile raw‑material pricing, geopolitical trade restrictions, and slower adoption of emerging modalities such as gene‑editing proteins that may shift purification preferences. Decision‑makers should monitor supply‑chain resilience and invest in R&D partnerships to capture emerging growth pockets. Furthermore, the emergence of continuous processing platforms is prompting vendors to develop SEC columns compatible with high‑throughput, inline monitoring, which could unlock additional market upside.

11 items

1. Executive Summary

2. Size Exclusion Chromatography (SEC) Column Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Size Exclusion Chromatography (SEC) Column Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Size Exclusion Chromatography (SEC) Column Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medical Consumable

6.1.2. Scientific Research

6.1.3. Others

6.2. Global Size Exclusion Chromatography (SEC) Column Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Oil Soluble SEC (GPC)

6.2.2. Water Soluble SEC (GFC)

6.3. Global Size Exclusion Chromatography (SEC) Column Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Size Exclusion Chromatography (SEC) Column Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Size Exclusion Chromatography (SEC) Column Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Size Exclusion Chromatography (SEC) Column Market Competition by Key Manufacturers

8.1. Global Size Exclusion Chromatography (SEC) Column Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Size Exclusion Chromatography (SEC) Column: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Agilent Technologies

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Shodex

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Tosoh Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. H&E

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Phenomenex

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Thermo Fisher Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Waters Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bioesn

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. ES Industries

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Sepax Technologies

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. YMC

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. NanoChrom Technologies (Suzhou)

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Beijing Green Herbs Science And Technology

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Liaoning Rengen Biosciences

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Welch Materials

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. BoRui Saccharide Biotech

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Size Exclusion Chromatography (SEC) Column Market

Figure 4: Global Size Exclusion Chromatography (SEC) Column Market: Drivers

Figure 5: Global Size Exclusion Chromatography (SEC) Column Market: Challenges

Figure 6: Global Size Exclusion Chromatography (SEC) Column Market: Trends

Figure 7: Global Size Exclusion Chromatography (SEC) Column Market: Opportunity

Figure 8: Global Size Exclusion Chromatography (SEC) Column Market: Restraint

Figure 9: Global Size Exclusion Chromatography (SEC) Column Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Size Exclusion Chromatography (SEC) Column Market Value (USD Million) By Region

Figure 15: Global Size Exclusion Chromatography (SEC) Column Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Size Exclusion Chromatography (SEC) Column Market Value (USD Million) By Region

Figure 23: Global Size Exclusion Chromatography (SEC) Column Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Size Exclusion Chromatography (SEC) Column Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Size Exclusion Chromatography (SEC) Column Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Size Exclusion Chromatography (SEC) Column Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Size Exclusion Chromatography (SEC) Column Market Value (USD Million) By Region

Table 10: Global Size Exclusion Chromatography (SEC) Column Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Size Exclusion Chromatography (SEC) Column Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Size Exclusion Chromatography (SEC) Column Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Size Exclusion Chromatography (SEC) Column Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Agilent Technologies Basic Information And Sales Area

Table 31: Agilent Technologies. Products Portfolio

Table 32: Shodex Basic Information And Sales Area

Table 33: Shodex. Products Portfolio

Table 34: Tosoh Corporation Basic Information And Sales Area

Table 35: Tosoh Corporation. Products Portfolio

Table 36: H&E Basic Information And Sales Area

Table 37: H&E. Products Portfolio

Table 38: Phenomenex Basic Information And Sales Area

Table 39: Phenomenex. Products Portfolio

Table 40: Thermo Fisher Scientific Basic Information And Sales Area

Table 41: Thermo Fisher Scientific. Products Portfolio

Table 42: Waters Corporation Basic Information And Sales Area

Table 43: Waters Corporation. Products Portfolio

Table 44: Bioesn Basic Information And Sales Area

Table 45: Bioesn. Products Portfolio

Table 46: ES Industries Basic Information And Sales Area

Table 47: ES Industries. Products Portfolio

Table 48: Sepax Technologies Basic Information And Sales Area

Table 49: Sepax Technologies. Products Portfolio

Table 50: YMC Basic Information And Sales Area

Table 51: YMC. Products Portfolio

Table 52: NanoChrom Technologies (Suzhou) Basic Information And Sales Area

Table 53: NanoChrom Technologies (Suzhou). Products Portfolio

Table 54: Beijing Green Herbs Science And Technology Basic Information And Sales Area

Table 55: Beijing Green Herbs Science And Technology. Products Portfolio

Table 56: Liaoning Rengen Biosciences Basic Information And Sales Area

Table 57: Liaoning Rengen Biosciences. Products Portfolio

Table 58: Welch Materials Basic Information And Sales Area

Table 59: Welch Materials. Products Portfolio

Table 60: BoRui Saccharide Biotech Basic Information And Sales Area

Table 61: BoRui Saccharide Biotech. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Size Exclusion Chromatography (SEC) Column Market Value (USD Million) By Region

Table 67: Global Size Exclusion Chromatography (SEC) Column Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current Size Exclusion Chromatography (SEC) Column market size?

The Size Exclusion Chromatography (SEC) Column market size was estimated at USD 1.15 billion in 2023, reflecting demand across biopharma, food safety, and environmental testing. This valuation incorporates both standard silica‑based columns and emerging polymer‑based product segments.

2. How is the market expected to grow through 2030?

The market is projected to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, with a future outlook of reaching roughly USD 1.9 billion by the end of the forecast period, driven by rising biologics pipelines and stricter quality standards.

3. What are the key drivers behind market expansion?

Key drivers include increasing biologics production, heightened regulatory scrutiny of protein therapeutics, and the need for rapid, high‑resolution purification. Additionally, expanding applications in polymer characterization and emerging demand for single‑use columns in GMP environments boost market momentum.

4. What challenges could impede market growth?

Challenges stem from high capital expenditure for advanced chromatography systems, limited raw‑material supply chains for specialty polymers, and intense price competition among low‑margin distributors. Moreover, the steep learning curve for new users can slow adoption of next‑generation SEC columns.

5. Which regions lead the SEC Column market?

North America remains the largest market, propelled by extensive biopharma R&D and robust funding. Europe follows, benefiting from stringent EU regulations, while the Asia‑Pacific region shows the fastest growth due to expanding pharmaceutical manufacturing and rising investment in analytical infrastructure.

6. Who are the top companies competing in this space?

Leading vendors include Cytiva (formerly GE Healthcare), Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, and Tosoh Bioscience. These firms differentiate through proprietary particle technologies, extensive product portfolios, and integrated service models that address both research‑scale and commercial‑scale purification needs.

7. What future opportunities exist for market participants?

Future opportunities arise from the growing adoption of continuous bioprocessing, integration of AI‑driven method development, and demand for high‑throughput screening columns in personalized medicine. Companies that invest in sustainable, single‑use column designs are positioned to capture emerging market share.

8. How are technological advances shaping the market?

Advances in monolithic polymer matrices, sub‑micron particle engineering, and hybrid silica‑polymer composites enhance column efficiency and robustness. These technologies shorten run times, improve resolution for large biomolecules, and enable compatibility with high‑pressure UHPLC platforms, reshaping the SEC Column landscape.

9. What regulatory considerations affect market dynamics?

Regulatory frameworks such as FDA’s Guidance for Industry on chromatography and EMA’s GMP requirements dictate column validation, traceability, and documentation. Compliance drives demand for certified, high‑purity columns and creates barriers for low‑cost, unqualified suppliers, influencing market structure.

Contact for Full Report

Loading report content...

How Big Is the Size Exclusion Chromatography (SEC) Column Market? Size, Share & Forecast 2033

Market Snapshot

Size Exclusion Chromatography (SEC) Column Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Size Exclusion Chromatography (SEC) Column Segmentation

Size Exclusion Chromatography (SEC) Column Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Size Exclusion Chromatography (SEC) Column market size?

2. How is the market expected to grow through 2030?

3. What are the key drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions lead the SEC Column market?

6. Who are the top companies competing in this space?

7. What future opportunities exist for market participants?

8. How are technological advances shaping the market?

9. What regulatory considerations affect market dynamics?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Size Exclusion Chromatography (SEC) Column Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Size Exclusion Chromatography (SEC) Column Segmentation

Size Exclusion Chromatography (SEC) Column Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Size Exclusion Chromatography (SEC) Column market size?

2. How is the market expected to grow through 2030?

3. What are the key drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions lead the SEC Column market?

6. Who are the top companies competing in this space?

7. What future opportunities exist for market participants?

8. How are technological advances shaping the market?

9. What regulatory considerations affect market dynamics?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation